CJC-1295 (with DAC)
Also known as: CJC-1295 DAC, Drug Affinity Complex
limited human dataWADA bannedNot FDA approvedResearch only
Published Dose Range
Low2 mg/week
Typical2-3 mg/week
High4 mg/week
2 mg SubQ 1-2x/week. Some sources say 2-3 mg/week. Half-life 5.8-8.1 days.
Published Cycle Range
Short8 wks
Typical10 wks
Long12 wks
8-12 weeks typical. Breaks every 12-16 weeks recommended.
Off-cycle: 4 weeks
Administration
Routessubcutaneous
Frequency1-2x weekly
Preferred timingPre-bed preferred; fasted state
AvoidAvoid carbs/fats within 1 hour of dosing
Enhances natural GH pulse during deep sleep
Safety Profile
Common side effects
- • Injection site reactions
- • Flushing
Requires monitoring
- • IGF-1 levels
Pregnancy / breastfeeding
No data — consult clinician
Common Misconceptions
- CJC-1295 alone can result in underwhelming results without a GHRP
- DAC version dosing is inconsistent across sources (2mg vs 2-3mg/week)
Commonly Stacked With
IpamorelinBPC-157TB-500MK-677
- Don't stack with MK-677 — redundant GH stimulation
Next Steps
Sign in to calculate your dose, add this compound to your stack, and check for interactions with your current cabinet.